Intuitive Venture Partners
VC Fund
New York, United States
Intuitive Venture Partners is a private equity and venture investment bank that specializes in raising venture and growth capital for emerging companies in technology, healthcare, and biotechnology. The firm was established in 2010 and is headquartered in New York, United States.
- Total investments:
- 13
- Last investment:
- Lead investor:
- 15%
Last updated:
For AI agents: llms.txt
Industries Intuitive Venture Partners invests in
Big DataHardwareSoftwareReal TimeHealth Care
Stages Intuitive Venture Partners invests in
Series BFunding RoundDebt FinancingVenture - Series UnknownSeries A
Countries Intuitive Venture Partners invests in
United States
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
David G. Landskowsky
|
|||
Eric Rubenstein
|
|||
|
Laura Etienne
|
|||
Tim Herrmann
|
|||
1 more contact available
Investment Focus
Industry
- Big Data 3 (23%)
- Hardware 2 (15%)
- Software 2 (15%)
- Real Time 2 (15%)
- Health Care 2 (15%)
Stage
- Series B 3 (23%)
- Funding Round 2 (15%)
- Debt Financing 2 (15%)
- Venture - Series Unknown 2 (15%)
- Series A 1 (8%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
David G. Landskowsky
Co-Founder and Partner
|
Co-Founder and Partner | Total investments: 0 | Find email | |
|
Eric Rubenstein
Co-Founder and Partner
|
Co-Founder and Partner | Total investments: 0 | Find email | |
|
Laura Etienne
Non-Member Manager
|
Non-Member Manager | Total investments: 0 | Find email | |
|
Tim Herrmann
Co-Founder and Partner
|
Co-Founder and Partner | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Lumicell
|
Lumicell is specializing in the field of image-guided cancer surgery. The company's technology illuminates cancer cells in the tumor cavity, enabling physicians to take action in real-time to improve patient outcomes. The company's lead product, consisting of a fluorescent optical contrast agent and a handheld illumination device, iscurrently under clinical investigation in patients undergoing breast cancer surgery. A planned pivotal study aims to evaluate the ability of the technology to reduce positive margin rates and reduce repeat surgeries while sparing healthy tissue. Lumicell technology is also being investigated in colorectal cancer, Barrett’s Esophagus, pancreatic cancer, and brain metastases. In clinical studies to date, no cancer has been missed and the safety profile of the optical contrast agent has been demonstrated.Lumicell was founded in 2008 and is based in Newton, MA, USA. | $2.7M / Venture - Series Unknown / Sep 10, 2024 | |
Eridan
|
Eridan is building the world’s first digital sampling radio for 4G, 5G, and beyond. Eridan's unique transceiver architecture produces all sub-6GHz cellular signals at full transmit power, eliminating the need for linear power amplifiers. This fully digital wireless signal generation approach consumes 5-10x less power to transmit the sameamount of data. | Venture - Series Unknown / Sep 06, 2024 | |
Slang
|
Slang.ai is a digital phone concierge that answers questions, takes reservations, and satisfies callers. | $12M / Series A / Jun 27, 2023 | |
|
Lumicell
|
Lumicell is specializing in the field of image-guided cancer surgery. The company's technology illuminates cancer cells in the tumor cavity, enabling physicians to take action in real-time to improve patient outcomes. The company's lead product, consisting of a fluorescent optical contrast agent and a handheld illumination device, iscurrently under clinical investigation in patients undergoing breast cancer surgery. A planned pivotal study aims to evaluate the ability of the technology to reduce positive margin rates and reduce repeat surgeries while sparing healthy tissue. Lumicell technology is also being investigated in colorectal cancer, Barrett’s Esophagus, pancreatic cancer, and brain metastases. In clinical studies to date, no cancer has been missed and the safety profile of the optical contrast agent has been demonstrated.Lumicell was founded in 2008 and is based in Newton, MA, USA. | $9M / Debt Financing / Sep 01, 2022 | |
HZO
|
HZO delivers customized protective nano and conformal coatings that safeguard electronics from the most demanding environments. It provides water protection solutions for electronics manufacturers by introducing a durable film to components during assembly. The company specializes in the fields of nanotechnology, waterproofing, electronics,nano-coating, full-submersion.It was founded in 2011 and headquartered in Morrisville, North Carolina. | Debt Financing / Jun 01, 2022 | |
HealthMine, Inc.
|
Health Care Data Analytics and Health Improvement Platform | $3.5M / Private Equity / Mar 01, 2022 | |
Bitvore
|
Bitvore provides tailored Intelligence Gathering and Analysis for business. The Bitvore platform is uniquely designed to consume multiple sources of continuously changing data, dynamically identify important information based on changing business needs, and share the results with other systems in real-time. Bitvore's patented cloud-based AIfactory uses massive data collection and hundreds of trained AI models to produce unprecedented precision intelligence about material changes to the businesses of the world. | $9M / Series B / Jan 01, 2022 | |
|
Lumicell
|
Lumicell is specializing in the field of image-guided cancer surgery. The company's technology illuminates cancer cells in the tumor cavity, enabling physicians to take action in real-time to improve patient outcomes. The company's lead product, consisting of a fluorescent optical contrast agent and a handheld illumination device, iscurrently under clinical investigation in patients undergoing breast cancer surgery. A planned pivotal study aims to evaluate the ability of the technology to reduce positive margin rates and reduce repeat surgeries while sparing healthy tissue. Lumicell technology is also being investigated in colorectal cancer, Barrett’s Esophagus, pancreatic cancer, and brain metastases. In clinical studies to date, no cancer has been missed and the safety profile of the optical contrast agent has been demonstrated.Lumicell was founded in 2008 and is based in Newton, MA, USA. | $34.8M / Debt Financing / Aug 01, 2021 | |
Virsec
|
At Virsec, we know a protection-first cybersecurity model is possible. By making server workloads self-protecting, we offer continuous protection, stopping known and unknown attacks—including zero days. With our revolutionary, patented technology, we secure software from the inside at runtime, precisely mapping what the app can do and stoppingmalicious code before it can run. Battle-tested against 200+ of the top government red-teamers and trusted by several Fortune100 companies, Virsec has repeatedly proven a protection-first model works. Virsec is headquartered in San Jose, California, with offices worldwide. | $100M / Series C / Jul 14, 2021 | |
Decklar
|
Roambee offers verifiably better supply chain visibility on demand, for on-time, in-full, in-condition delivery of shipments and assets anywhere in the world. 300+ enterprises are improving customer experience, service levels, product quality, cash cycles, business efficiencies, and sustainability with Roambee’s real-time insights & foresights.More than 50 of them are the top 100 global companies in the Pharma, Food, Electronics, Chemicals, Automotive, Packaging & Containers, and Logistics sectors. The company’s innovative AI-powered platform and end-to-end monitoring solutions deliver reliable, timely, and actionable “supply chain signals” that drive logistics automation. These curated supply chain signals are built on item-level, firsthand IoT sensor data and non-sensor inputs for high accuracy. This enables better multimodal ETAs, OTIF deliveries, 80%+ cold chain compliance, and more, including 4X+ ROI on supply chain assets such as bins, tanks, containers, work in process (WIP), and in-store/warehouse inventory by optimizing utilization and inventory levels. Gartner identifies Roambee as one of the 9 global supply chain technology companies in “2021 Gartner Tracking and Monitoring Business Process Context: Magic Quadrant for Real-Time Transposition Visibility Platforms.” Roambee is also behind the safe and timely distribution of temperature-sensitive vaccines for one of the largest global COVID-19 vaccine makers and food assistance for one of the largest humanitarian organizations in the world. Roambee is headquartered in the Silicon Valley, USA, and is globally operational with offices in Mexico, Brazil, UK, Switzerland, Germany, UAE, India, Singapore, Malaysia, and Indonesia. | $15.2M / Series B / Jan 28, 2020 | |
| See all 13 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
SaaS Investors
99,274 investors
Software Investors
50,021 investors
Health Care Investors
43,014 investors
Hardware Investors
40,144 investors
Big Data Investors
10,744 investors
SaaS VC Funds
61,208 investors
Software VC Funds
31,919 investors
Health Care VC Funds
32,370 investors
Hardware VC Funds
30,945 investors
FAQ
What does Intuitive Venture Partners invest in?
Intuitive Venture Partners invests primarily in Big Data, Hardware and Software startups, most often at Series B and Funding Round stage. Most of the 13 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Intuitive Venture Partners?
Public channels for Intuitive Venture Partners include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Intuitive Venture Partners?
The team at Intuitive Venture Partners includes David G. Landskowsky (Co-Founder and Partner), Eric Rubenstein (Co-Founder and Partner) and Laura Etienne (Non-Member Manager). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
